Biofarm (BSE:BIO) Total Stockholders Equity : lei510.6 Mil (As of Mar. 2025)

View and export this data going back to 1996. Start your Free Trial

What is Biofarm Total Stockholders Equity?

Biofarm's Total Stockholders Equity for the quarter that ended in Mar. 2025 was lei510.6 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Biofarm's Book Value per Share for the quarter that ended in Mar. 2025 was lei0.52. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Biofarm's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.00.

Biofarm Total Stockholders Equity Historical Data

The historical data trend for Biofarm's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biofarm Total Stockholders Equity Chart

Biofarm Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

291.55

332.79

380.06

434.41

478.26

Biofarm Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															455.03	445.86	477.12	478.26	510.59

Biofarm (BSE:BIO) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Biofarm's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(510.587	-	0)	/	985.367
	=	0.52

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Biofarm's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	1.013)	/	510.587
	=	0.00

Biofarm Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Biofarm's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Biofarm Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biofarm SA (BSE:BIO) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

99 Logofatul Tautu Street, Sector 3, Bucharest, ROU, 031212

Website

https://www.biofarm.ro

Biofarm SA is a company engaged in production and marketing in the pharmaceutical sector. It is involved in the manufacture and wholesale of over-the-counter drugs, prescription medications, and dietary supplements. The firm's product portfolio includes pharmaceutical preparations for the digestive system, musculoskeletal system, immune stimulation, respiratory system, cold & flu symptoms, and venous circulation improvement, as well as multivitamins, antioxidants, antiseptics, disinfectants, and cosmetics, among others. Some of its brands are Triferment, Colebil, Cavit, Anghirol, Clorocalcin, and Bixtonim. Additionally, the company offers services, such as investment in research, promotion, and packaging.